This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, J. Articles by Haber, D. A. Search for Related Content PubMed PubMed Citation Articles by Zhang, J. Articles by Haber, D. A.

Negative Regulation of YAP by LATS1 Underscores Evolutionary Conservation of the Drosophila Hippo Pathway

Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts

Requests for reprints: Daniel A. Haber, Massachusetts General Hospital Cancer Center, Building 149, 13th Street, Charlestown, MA 02129. Phone: 617-726-7805; Fax: 617-724-6919; E-mail: haber{at}helix.mgh.harvard.edu.

Key Words: YAP • LATS • Hippo pathway • EMT • cancer

The Hippo pathway defines a novel signaling cascade regulating cell proliferation and survival in Drosophila, which involves the negative regulation of the transcriptional coactivator Yorkie by the kinases Hippo and Warts. We have recently shown that the human ortholog of Yorkie, YAP, maps to a minimal amplification locus in mouse and human cancers, and that it mediates dramatic transforming activity in MCF10A primary mammary epithelial cells. Here, we show that LATS proteins (mammalian orthologs of Warts) interact directly with YAP in mammalian cells and that ectopic expression of LATS1, but not LATS2, effectively suppresses the YAP phenotypes. Furthermore, shRNA-mediated knockdown of LATS1 phenocopies YAP overexpression. Because this effect can be suppressed by simultaneous YAP knockdown, it suggests that YAP is the primary target of LATS1 in mammalian cells. Expression profiling of genes induced by ectopic expression of YAP or by knockdown of LATS1 reveals a subset of potential Hippo pathway targets implicated in epithelial-to-mesenchymal transition, suggesting that this is a key feature of YAP signaling in mammalian cells. [Cancer Res 2008;68(8):2789–94]

This article has been cited by other articles:

				H. W. Peng, M. Slattery, and R. S. Mann Transcription factor choice in the Hippo signaling pathway: homothorax and yorkie regulation of the microRNA bantam in the progenitor domain of the Drosophila eye imaginal disc Genes & Dev., October 1, 2009; 23(19): 2307 - 2319. [Abstract] [Full Text] [PDF]

				S. W. Chan, C. J. Lim, L. S. Loo, Y. F. Chong, C. Huang, and W. Hong TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation J. Biol. Chem., May 22, 2009; 284(21): 14347 - 14358. [Abstract] [Full Text] [PDF]

				B. Zhao, J. Kim, X. Ye, Z.-C. Lai, and K.-L. Guan Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein Cancer Res., February 1, 2009; 69(3): 1089 - 1098. [Abstract] [Full Text] [PDF]

				T. Oka, V. Mazack, and M. Sudol Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP) J. Biol. Chem., October 10, 2008; 283(41): 27534 - 27546. [Abstract] [Full Text] [PDF]

				B. V. V. G. Reddy and K. D. Irvine The Fat and Warts signaling pathways: new insights into their regulation, mechanism and conservation Development, September 1, 2008; 135(17): 2827 - 2838. [Abstract] [Full Text] [PDF]